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ABSTRACT 
Now a day there has been exponential increase in interest in developing nanoparticles for novel drug delivery system. Nanoparticles provide 
many advantages over conventional drug delivery system like improved pharmacokinetic property; enhance bioavailability, smaller drug dose 
required for the treatment. Recently solid lipid nanoparticles (SLN) materialized as novel approach to oral and parenteral drug delivery system. 
SLN possess a solid lipid core that can solubilise lipophilic drug. Lipid core was stabilised by using surfactant (emulsifier). SLN can be prepared 
by using various precursors like emulsion, micro emulsion, and SLM can be prepared by using lipid coated microcrystal. These precursors 
further proceed to obtain particles of desired size and shape by making use of various techniques and equipment’s. Each precursor show benefits 
along with some limitations. 
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A solid lipid nanoparticle is typically spherical in shape or 
some time bicontionous structure with an avg. Diameter b/w 
10-1000 nm. In SLN drug is encapsulated in lipid matrix 
which is stabilised by using surfactant or co-surfactant or by 
using mixture of surfactant. Combination of surfactants 
prevents particles agglomeration more efficiently. Lipid used 
in SLN preparation are triglyceride i.e. Tristearin, 
Monoglyceride i.e. Glycerol Monostearate, steroids and 
wax’s. There are various methods which uses different types 
of precursors for the preparation of solid nanoparticles. 
These precursors provide intermediates to the obtain nano-
particles of desired size. Precursor chosen for the 
preparation of SLN depends on size of particle which we 
want to obtain. Some precursors like emulsion, micro 
emulsion produce SLN whereas some precursors and 
methods produce SLM (solid lipid micro particles). Various 
solvents used during preparation of precursor which 
removed completely at final step of SLN formation which is 
important from toxicological point of view. Precursors used 
for SLN preparation are namely:- 
1) Emulsion 
It is mixture of two or more immiscible liquid which consist 
a fine dispersion of minute droplets of one liquid into 
another with or without emulsifier. It is widely used as 
precursor for the synthesis of SLN. 
Emulsion can be o/w or w/o type or either w/o/w or o/w/o. 
SLN can be prepared through emulsion by following 
techniques:- 
1.1) By Hot Homogenisation 
1.11) high pressure homogenisation (HPH):- various 
approaches are applied in hot homogenisation technique to 
obtain SLN. SLN can be prepared by hot homogenisation, 
which involve high shear and ultrasonic homogenisation. It 
is used for polymeric nanoparticles production by allowing 
production of colloidal suspension of SLN without solvent 
which is good from toxicological point of view. Size of 
obtained nanoparticles below 500nm by hot homogenisation 
and low micro particle content but major drawback is that it 
can’t use for Thermosensitive drug substance due thermal 
exposure and for encapsulating hydrophilic drug. First 
problem can be overcome by using cold homogenisation 
techniques but its gives larger particles as compare to 
particles obtained by hot homogenisation. Second problem 
can resolve by LDC (lipid-drug conjugate) system. In this 
system drug conjugated with lipid either by covalent linking 
or by salt formation then formed LDC proceed for 
nanoparticle preparation. 
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1.12) high shear and ultrasound homogenisation: - these two 
methods are widely used and can easily handle. Both these 
method used to improve dispersion quality of micro 
particles. SLN particles prepared by these methods consist 
suitable emulsifying agent which allows formation hot 




Figure 1: drug partitioning when hot homogenization technique used for SLN preparation. 1 
 
1.2) Melt Dispersion Technique:-by employing this technique 
micro particles obtained from emulsion. For lipophilic and 
hydrophilic drug o/w and w/o type emulsion used 
respectively. Lipophilic drug nanoparticles prepared by 
dissolving drug in melted lipid and then emulsified in hot 
surfactant solution using high shear for mixing, then obtain 
emulsion cooled at room temperature to get solid lipid micro 
particles2.  Whereas for preparing nanoparticles of 
hydrophilic drug, aqueous solution of drug emulsified with 
melted lipid and then put in external aqueous phase to 
obtain w/o/w emulsion then it cooled to room temperature 
to obtain solid micro particles of 1-250µm in diameter3.  
1.3) Supercritical Fluid Extraction Of Emulsion (SFEE):-this 
method based on extraction of solvent from emulsion by 
passing through extraction column with supercritical co2 in 
concurrent direction. Extraction efficiency depend on 
operating temperature and pressure. In this method drug in 
dissolved in melted lipid and emulsified with aqueous 
solution of surfactant and then homogenised to obtain fine 
emulsion. Then obtained o/w emulsion introduced in 
extraction column and simultaneously supercritical co2 
introduced from bottom counter-currently at constant 
temperature (35°c) and pressure (80bar). 
Solvent extraction occur when emulsion come in contact 
with supercritical co2 and expansion of organic phase occur 
due to inverse flux of supercritical co2 into emulsion droplet 
and leads to precipitation of lipid-drug material dissolved in 
organic phase4 . 
Advantage:-this method is high solvent extraction efficiency 
as compare to other conventional methods. This method 
ensures complete removal of solvent which is important 
from toxicological point of view. Particle obtained by this 
method have mean diameter b/w 20-90nm in diameter4. 
1.4) Phase Inversion Temperature (Pit):-this method uses the 
concept of ability of Polyethoxylated surfactants to change 
their affinity toward oil and water with temperature. In this 
method, surfactant used which leads to conversion of 
emulsion from o/w type to w/o when heated above pit and 
again converted back when temperature decreases below 
pit5 . 
Pit method used for preparation of nanoparticles and nano-
capsules. Now days it is used for the preparation of SLN. In 
which it consist oil phase and aqueous phase. Oil phase 
consist solid lipid and non-ionic surfactant and aqueous 
phase consist NaCl. Both phases heated separately at equal 
temperature above pit i.e. approximately 90c. Then aqueous 
phase added drop wise in oily phase under agitation and 
obtain w/o emulsion. Then it cool at room temp below pit 
and then o/w emulsion formed and SLN obtained of 30-
100nm in diameter6.  
2) Micro Emulsion as Precursor 
Micro emulsion is also commonly used as precursor for SLN 
preparation. Particle size of droplet in micro emulsion varies 
from 10-80 nm. Particles shape of micro emulsion is not 
static its various from droplet like swollen micelle’s to 
bicontionous structure. Microemulsion has two unique 
properties one is it has low interface tension b/w oil and 
water interface and second one is highly flexible interface 
which is obtained by using suitable co-surfactant7 . 
Techniques used to prepare SLN from micro emulsion are:- 
2.1) Micro emulsion dilution technique (MDT) - this method 
first used by Gasco (researcher) for the preparation of SLN. 
This method can used for both lipophilic as well as for 
hydrophilic drug because of great solubilisation property off 
micro emulsion8,9 . SLN prepared by this method consist 
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formation of o/w type micro emulsion which is prepared by 
using melted lipid and by aqueous solution of surfactant and 
co-surfactant under stirring. Then formed micro emulsion 
cooled by diluting with water volume 10-200 times of micro 
emulsion and get SLN with reduced particle size and small 
size distribution. 
B) Micro emulsion cooling technique (MCT):-in this method 
SLN prepared from o/w emulsion by cooling at 4°c without 
diluting the emulsion. Emulsion obtained by melting 
emulsifying wax. This method operates at mild temp, less 
time consuming and high drug entrapment is obtainable 10. 
Particle size of obtained nanoparticles varies from 50-
300nm. 
3) Soap Micellar Solution as Precursors 
This method based on coacervation technique which 
produces particles of 200-1000nm size. In this method 
interaction b/w micellar solution of fatty acid alkaline 
solution and acid solution takes place. As proton exchange 
proceed b/w coacervation solution and soap solution, fatty 
acid get precipitates11,12 . 
This method not uses drug incorporation in solvent and 
complex equipment’s for SLN preparation. Drug incorporates 
in micellar solution which is obtained at Kraft point. Good 
solubilising property of micellar solution help in loading 
poorly soluble drug13,14  and give high drug loading in SLN. 
Particle size of SLN depends on micellar solution 
concentration and grade of polymer used for stabilisation. 
4) Using Water Miscible Solvent System 
This method is developed to encapsulate drug to get 
enhanced stability and bioavailability. This method operates 
at mild temperature which makes it useful for Thermoliable 
drug substance. Different method used for SLN using water 
miscible solvent system 
4.1) solvent injection method: - in this method drug and lipid 
dissolved in water miscible solvent which is injected in 
water phase through syringe needle with continuous 
stirring. Then water is added which result into precipitation 
of lipid, encapsulating drug. Particle size of obtained SLN 
depends on type of lipid, surfactant, and solvent used in 
preparation and also depends on viscosity of external phase. 
This method produces nanoparticles of 100-500nm in 
diameter. 
4.2) solvent evaporation method: - in this method o/w 
emulsion prepared for lipophilic drug which is dissolved in 
inner organic phase15  and w/o emulsion for hydrophilic 
drug that is dissolved in inner aqueous phase system 16,17. 
In this method lipid matrix dissolved in water immiscible 
organic solvent which is emulsified aqueous phase then 
solvent is removed under reduced pressure which results 
into precipitation of lipid matrix and nanoparticles formed of 
30-500nm in diameter16,18 . But this method become out 
dated because nanoparticles are formed by removal of 
solvent by evaporation and chances of solvent residue 
remain left which is not good from toxicological point of 
view.  
 Organic solvent and prepare emulsion of o/w type. When 
this emulsion poured in water, drug start to solidify which is 
dissolved in organic solvent due to diffusion of solvent from 
droplet to continuous phase. 
Solvent used like benzyl alcohol, methyl ethyl acetone, ethyl 
Formate in this method give good quality drug loaded PGLA 
microsphere19.  
5) Coarse and Fine Suspension as Precursors 
SLN prepared by this precursor requires one step process 
which convert particle of suspension directly into solid 
nanoparticles. This precursor used as feed solution which 
first atomised by various technique like pneumatic and 
ultrasonic atomisation to get spray foam, then it come in 
contact with hot gas, which results into formation solid dried 
particles due to evaporation solvent20 . Obtained dried 
particles separated by cyclone. 
Advantage:-in this technique various parameter can be 
controlled like droplet size, solute concentration, relative 
humidity and temperature and which is helpful in 
characterisation of obtained nanoparticles21.  
6) Solid Lipid Micro Particles as Precursor 
SLM produced from ethanolic solution of lipid and drug. It 
can prepared by various method spry drying and spray 
congealing method. SLM prepared by spry drying method is 
smaller and more homogenous in nature. Shape of the 
particles influenced by: 
(i) Drying rate 
(ii) Viscosity of liquid which constitute feed 
(iii) Surface tension 
Whereas in electrospray method, SLM and SLN prepared by 
forming alcoholic solution of lipid which is used for 
preparing particles of nearly 1µm in diameter. The solution 
contained in syringe which is connected with metallic 
capillary. Then solution passed through syringe under the 
influence of electric field and solvent get evaporated during 
travelling. 
Particle size and shape depend on solvent and applied 
voltage22,23.  
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Figure 3: (a) standard electrospray. (b) Coaxial electrospray. (c) Multiplexed electrospray 
 
7) Micronized Lipid Matrix (Mlm) 
MLM prepared by cryogenic micro ionisation method. In this 
firstly lipid matrix prepared by melts dispersing or solvent 
stripping. In melt dispersion, drug dissolved in molten lipid 
whereas in solvent stripping, drug and lipid dissolved in 
mixture of solvent.  
Obtained lipid matrix cooled in liquid nitrogen at -80°c. Then 
grind to obtain micronized lipid matrix. Obtained particles 
then sieved and get particles size varies from 1-500µm in 
diameter. 
8) Coated Microcrystals as a Precursor 
Coated microcrystal prepared by rapid expansion of 
supercritical solution (REES) also called supercritical fluid 
nucleation. In this method matrix dissolve in supercritical 
fluid (SCF) and expanded passing through nozzle to get 
particles25. 
In modified REES method lipid coated BSA (bovine albumin 
serum)26 used for SLN preparation. Coating is done by REES 
method. In which coating material and BSA microcrystal 
placed in autoclave hang rotating impeller, heated and 
pressurised with co2 (temperature range 35-40°c and 
pressure about 200 bar). The system is left to achieve 
equilibrium at these conditions which results into 
solubilisation of coating material in SCF. Then autoclaved 
cooled which lead to decrease in pressure and phase change 
from SCF to liquid phase and coating material become 
insolubilize and get precipitate over BSA microcrystal and 
coated BSA particle’s collected from bottom. 
  
 
Figure 4: scemtic represention of coating process.(a)filling step: bsa particle represented in white and coating material 
represend in black.(b)solubilisation of coating material in scf co2.(c)decompression phase: insolubilisation of coating material). 
(d) harvesting of coated particles27. 
 
9) Particles from Gas Saturated 
Solution/Suspension 
Gas saturated solution/suspension expanded by using nozzle 
to prepare nanoparticles. Gas saturated solution can be 
prepared by gas assisted melting atomisation (GAMA) in 
which melted material mixed with SCF i.e. co2 under 
pressure and then expanded by passing through nozzle. 
During travelling of saturated solution, SCF get vaporize and 
dry fine particle are collected. Then these particles are used 
to prepare suspension by dispersing these particles in water. 
Prepared suspension further expanded by passing through 
nozzle to get nano sized particles. 
10) Using Lipid and Water Phase as Separate 
Entities 
SLN can be prepared by passing lipid and water phase as 
separately through membrane contractor made up of 
Kerasep ceramic membrane28 [28]. In this lipid material 
heated in pressurised vessel and passed through membrane 
pores which results into formation of small articles which 
detached from membrane due to tangential flow of water. 
Then obtained water dispersion cooled to get SLN of 100-
200nm in diameter. Particle size depends on type and 
concentration of surfactant used in formulation29.  
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Figure 5: schematic diagram of membrane contractor for 
SLN preparation27 
 
Figure 6: experimental setup for SLN preparation by 
membrane contractor27 
CONCLUSION 
Various precursors are used to prepare SLN by employing 
different-2 type of techniques to obtain particles of different 
size and shape. Material used in SLN preparation should be 
safe and biocompatible. Solvent used in precursor formation 
should remove from final preparation because traces of 
solvent are not safe from toxicological point of view. 
Precursor chosen for SLN preparation depends on particle 
size and shape and to enhance drug entrapment and 
physiochemical parameter. 
Each precursor leads to formation of particle with different 
size. Every precursors show advantage and some limitation. 
Selection of precursor for preparation of SLN depend on 
benefit to limitation ratio, size of particle which we want to 
obtain, safety from toxicological point of view, 
reproducibility, feasibility, and characteristics of drug 
encapsulated within particles. 
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